Kyverna Therapeutics Inc.

KYTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.12

-$0.01 (-0.14%)

At close: Sep 21, 2026, 4:00 PM ET

$7.07

-$0.05 (-0.64%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $433.47M

Enterprise Value $241.55M

Beta 1.99

Average Volume 946.83K

Shares Outstanding (Diluted) 60.9M

Shares Change YoY 40.88%

Institutional Ownership 57.62%

Exchange NASDAQ

ISIN US5019761049

Price Performance

Price Change 1M -14.4%

Price Change 3M -15.5%

Price Change 6M -9.5%

Price Change YTD -18.8%

Price Change 1Y 9.2%

Price Change 3Y -76.3%

Price Change 5Y -76.3%

1M CAGR (ann.) -8.0%

1Y CAGR (ann.) 63.2%

5Y CAGR (ann.) N/A

All-Time CAGR -42.4%

Valuation

PE Ratio -2.42

Forward PE N/A

PEG Ratio -0.11

Forward PEG -0.25

PS Ratio N/A

Forward PS 28.50

PB Ratio 2.61

P/FCF Ratio -2.72

P/Adj. FCF Ratio -2.52

P/OCF Ratio -2.73

EV/Sales N/A

EV/EBIT -1.60

EV/EBITDA -1.62

EV/FCF -1.52

Earnings Yield -41.3%

FCF Yield -36.8%

Adj. FCF Yield -39.6%

Financial Health

Net Cash $191.31M

Total Debt $8.12M

Cash & Short-Term Investments $199.43M

Total Assets $219.82M

Current Ratio 9.06

Quick Ratio 9.06

Debt / Equity Ratio 0.20

Debt / EBITDA -0.05

Debt / FCF -0.05

OCF / Debt -19.56

Interest Coverage -88.69

Altman Z-Score 0.33

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -7.6%

Returns

Return on Assets -69.4%

Return on Equity -81.9%

Return on Invested Capital -80.0%

Return on Capital Employed -80.7%

Return on Tangible Assets -69.4%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -5.0%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -30.5%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y -7.6%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.68

EPS Growth Est (next Q) -20.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $25

Price Target Upside 251.1%

Cash Flow

Operating Cash Flow $-158.75M

Free Cash Flow $-159.43M

Adj. Free Cash Flow $-171.51M

FCF Per Share -$2.62

OCF Per Share -$2.61

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-351K

Operating Income $-158.93M

EBITDA $-149.41M

Net Income $-152.64M

EPS (Diluted) -$2.94

Revenue / Employee N/A

Profit / Employee $-1.02M

Employees 149